|
|
|
MIRA
INFORM REPORT
|
Report No. : |
489800 |
|
Report Date : |
03.02.2018 |
IDENTIFICATION DETAILS
|
Name : |
INTERHEALTH NUTRACEUTICALS INCORPORATED |
|
|
|
|
Registered Office : |
5451 Industrial Way, Benicia CA 94510, USA |
|
|
|
|
Country : |
United States |
|
|
|
|
Date of Incorporation : |
07.10.1987 |
|
|
|
|
Legal Form : |
Corporation |
|
|
|
|
Line of Business : |
Subject researches, develops, manufactures, markets, and distributes
nutritional ingredients to manufacturers of dietary supplements and
functional foods, foods and beverages, cosmetic products, and animal health
products worldwide. |
|
|
|
|
No. of Employees : |
30 |
RATING & COMMENTS
(Mira Inform has adopted New Rating mechanism w.e.f. 23rd
January 2017)
|
MIRA’s Rating : |
A |
|
Credit Rating |
Explanation |
Rating Comments |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Exist |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List
|
Country Name |
Previous Rating (30.06.2017) |
Current Rating (30.09.2017) |
|
United States |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderately Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderately High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
UNITED STATES - ECONOMIC OVERVIEW
The US has the most technologically powerful economy in the world, with
a per capita GDP of $57,300. US firms are at or near the forefront in
technological advances, especially in computers, pharmaceuticals, and medical,
aerospace, and military equipment; however, their advantage has narrowed since
the end of World War II. Based on a comparison of GDP measured at purchasing
power parity conversion rates, the US economy in 2014, having stood as the
largest in the world for more than a century, slipped into second place behind
China, which has more than tripled the US growth rate for each year of the past
four decades.
In the US, private individuals and business firms make most of the
decisions, and the federal and state governments buy needed goods and services
predominantly in the private marketplace. US business firms enjoy greater
flexibility than their counterparts in Western Europe and Japan in decisions to
expand capital plant, to lay off surplus workers, and to develop new products.
At the same time, businesses face higher barriers to enter their rivals' home
markets than foreign firms face entering US markets.
Long-term problems for the US include stagnation of wages for
lower-income families, inadequate investment in deteriorating infrastructure,
rapidly rising medical and pension costs of an aging population, energy
shortages, and sizable current account and budget deficits.
The onrush of technology has been a driving factor in the gradual
development of a "two-tier" labor market in which those at the bottom
lack the education and the professional/technical skills of those at the top
and, more and more, fail to get comparable pay raises, health insurance
coverage, and other benefits. But the globalization of trade, and especially
the rise of low-wage producers such as China, has put additional downward
pressure on wages and upward pressure on the return to capital. Since 1975,
practically all the gains in household income have gone to the top 20% of
households. Since 1996, dividends and capital gains have grown faster than
wages or any other category of after-tax income.
Imported oil accounts for nearly 55% of US consumption and oil has a
major impact on the overall health of the economy. Crude oil prices doubled
between 2001 and 2006, the year home prices peaked; higher gasoline prices ate
into consumers' budgets and many individuals fell behind in their mortgage
payments. Oil prices climbed another 50% between 2006 and 2008, and bank
foreclosures more than doubled in the same period. Besides dampening the
housing market, soaring oil prices caused a drop in the value of the dollar and
a deterioration in the US merchandise trade deficit, which peaked at $840
billion in 2008. Because the US economy is energy-intensive, falling oil prices
since 2013 have alleviated many of the problems the earlier increases had
created.
The sub-prime mortgage crisis, falling home prices, investment bank
failures, tight credit, and the global economic downturn pushed the US into a
recession by mid-2008. GDP contracted until the third quarter of 2009, making
this the deepest and longest downturn since the Great Depression. To help
stabilize financial markets, the US Congress established a $700 billion
Troubled Asset Relief Program (TARP) in October 2008. The government used some
of these funds to purchase equity in US banks and industrial corporations, much
of which had been returned to the government by early 2011. In January 2009,
Congress passed and President Barack OBAMA signed a bill providing an
additional $787 billion fiscal stimulus to be used over 10 years - two-thirds
on additional spending and one-third on tax cuts - to create jobs and to help
the economy recover. In 2010 and 2011, the federal budget deficit reached
nearly 9% of GDP. In 2012, the Federal Government reduced the growth of
spending and the deficit shrank to 7.6% of GDP. US revenues from taxes and
other sources are lower, as a percentage of GDP, than those of most other
countries.
Wars in Iraq and Afghanistan required major shifts in national resources
from civilian to military purposes and contributed to the growth of the budget
deficit and public debt. Through 2014, the direct costs of the wars totaled
more than $1.5 trillion, according to US Government figures.
In March 2010, President OBAMA signed into law the Patient Protection
and Affordable Care Act, a health insurance reform that was designed to extend coverage
to an additional 32 million Americans by 2016, through private health insurance
for the general population and Medicaid for the impoverished. Total spending on
healthcare - public plus private - rose from 9.0% of GDP in 1980 to 17.9% in
2010.
In July 2010, the president signed the DODD-FRANK Wall Street Reform and
Consumer Protection Act, a law designed to promote financial stability by
protecting consumers from financial abuses, ending taxpayer bailouts of
financial firms, dealing with troubled banks that are "too big to
fail," and improving accountability and transparency in the financial
system - in particular, by requiring certain financial derivatives to be traded
in markets that are subject to government regulation and oversight.
In December 2012, the Federal Reserve Board (Fed) announced plans to
purchase $85 billion per month of mortgage-backed and Treasury securities in an
effort to hold down long-term interest rates, and to keep short-term rates near
zero until unemployment dropped below 6.5% or inflation rose above 2.5%. In
late 2013, the Fed announced that it would begin scaling back long-term bond
purchases to $75 billion per month in January 2014 and further reduce them as
conditions warranted; the Fed ended the purchases during the summer of 2014. In
2014, the unemployment rate dropped to 6.2%, and continued to fall to 5.5% by
mid-2015, the lowest rate of joblessness since before the global recession
began; inflation stood at 1.7%, and public debt as a share of GDP continued to
decline, following several years of increases. In December 2015, the Fed raised
its target for the benchmark federal funds rate by 0.25%, the first increase
since the recession began. With US GDP growth below 2%, the Fed opted to raise
rates three times since then, and in mid-June 2017, the range for the target
rate stood at 1% to 1.25%.
|
Source
: CIA |
STATUTORY INFORMATION |
|
|
Legal Name: |
INTERHEALTH NUTRACEUTICALS INCORPORATED |
|
Trade Names: |
INTERHEALTH NUTRACEUTICALS INCORPORATED |
|
ID: |
C1199303 |
|
Date Created: |
1987 |
|
Date Incorporated: |
10/07/1987 |
|
Legal Address: |
5451 Industrial Way Benicia CA 94510, USA |
|
Operative Address: |
5451 Industrial Way Benicia CA 94510, USA |
|
Telephone: |
1-800-783-4636 707-751-2800 |
|
Fax: |
707-751-2801 |
|
Legal Form: |
Corporation |
|
Email: |
info.benicia@lonza.com |
|
Registered in: |
CALIFORNIA |
|
Website: |
www.interhealthusa.com |
|
Contact: |
Ms. Mary Helen Lucero - Chief Financial Officer |
|
Staff: |
30 |
|
Activity: |
NAICS 1: Medicinal and Botanical Manufacturing SIC 1: Vitamins, Natural Or Synthetic: Bulk, Uncompounded |
|
|
|
|
Banks: |
BANK OF AMERICA |
|
|
|
|
History: |
InterHealth Nutraceuticals, Inc. was founded in 1987 and is based in
Benicia, California. |
|
|
|
|
Parent Company: |
As of September 13, 2016, InterHealth Nutraceuticals, Inc. operates as
a subsidiary of: Lonza Group Ltd Muenchensteinerstrasse 38 Basel, 4002 Switzerland |
|
|
|
PRINCIPAL ACTIVITY |
|
|
|
InterHealth Nutraceuticals, Inc. researches, develops, manufactures,
markets, and distributes nutritional ingredients to manufacturers of dietary
supplements and functional foods, foods and beverages, cosmetic products, and
animal health products worldwide. |
|
Products/Services description: |
It offers Aller-7, a blend of herbal extracts to support respiratory
health and normal breathing; ChromeMate, a chromium polynicotinate that helps
increase the effectiveness of chromium, an essential trace mineral that helps
support blood sugar levels; OptiZinc and L-OptiZinc that are forms of
methionine-bound zinc, an essential trace mineral required for proper immune
function, eye health, cardiovascular health, prostate health, and healthy
testosterone levels; and LOWAT and Meratrim that are weight-management
ingredients. The company also provides OptiBerry, a dietary supplement
ingredient; Protykin a Polygonum cuspidatum extract that helps support
healthy aging; Super CitriMax, a fruit extract ingredient for weight
management; UC-II, a dietary ingredient that supports joint comfort,
mobility, and flexibility; ZMA, an anabolic support formula maintaining
healthy testosterone levels, and supporting muscle strength and muscle power;
and other ingredients. |
|
Brands: |
INTERHEALTH NUTRACEUTICALS |
|
Sales are: |
Wholesale |
|
Clients: |
Dsm Nutritional Products Mexico SA de CV |
|
Suppliers: |
Natural Remedies Pvt Ltd Laila Nutraceuticals Fysolate Technologies |
|
Operations area: |
National and International |
|
The company imports from |
INDIA |
|
The company exports to |
MEXICO |
|
The subject employs |
30 employees |
|
Payments: |
No Complaints |
|
|
|
LOCATION |
|
|
Headquarters : |
5451 INDUSTRIAL WAY BENICIA CA 94510, USA |
|
Comments on Address: |
- |
|
Branches: |
No other branches were found. |
|
Related Companies: |
No related companies were found. |
|
|
|
GROUP STRUCTURE AND SUBSIDIARY COMPANIES |
|
|
Listed at the stock exchange: |
NO |
|
Capital: |
NA |
|
Shareholders: |
The company does not disclose information on shareholders. The
following information has been obtained through private sources. As of September 13, 2016, InterHealth Nutraceuticals, Inc. operates as
a subsidiary of: Lonza Group Ltd Muenchensteinerstrasse 38 Basel, 4002 Switzerland This information was confirmed by the company. |
|
Management: |
Ms. Mary Helen Lucero - Chief Financial Officer Fredrick Zilz - Technicals Operations Director Mr. William Seroy - Founder, Chairman and President Mr. Navpreet Singh Ph.D., MBA - Vice President of Operations Dr. Jim Lugo Ph.D. - Vice President of Business Development and
Research |
|
|
|
FINANCIAL INFORMATION |
|
|
|
The company does not make its financial
statements public. The following information has been provided by private
sources: |
|
|
|
|
USD 2016 |
|
|
Gross Revenue |
8.400.000 |
|
Cash flow |
Normal |
|
|
|
LEGAL FILINGS |
|
|
|
|
|
PATENTS |
Method and composition for preventing or reducing the symptoms of
insulin resistance syndrome Publication number: 20050100614 Abstract: A method for preventing and or reducing the symptoms of
insulin resistance and a related syndrome in persons comprises identifying
persons having or at risk for having such symptoms, and administering to them
an effective amount of a composition comprising niacin-bound chromium that
prevents or reduces the symptoms. Compositions incorporating niacin-bound
chromium and additional compounds also are disclosed that are particularly
effective in synergistically preventing or reducing these symptoms. Type: Application Filed: December 9, 2004 Publication date: May 12, 2005 Applicant: InterHealth Nutraceuticals Incorporated Inventors: Debasis Bagchi, Harry Preuss, Shil Kothari Compositions incorporating (-)-hydroxycitric acid, chromium, and
gymnemic acid, and related methods for promoting healthy body weight and
improving related health factors Publication number: 20050013887 Abstract: Methods for promoting healthy body weight and improving a
variety of related physiological factors, including serum serotonin levels,
serum leptin levels, fat oxidation, cholesterol levels, and body mass index,
in persons or other mammals, include administering to those persons or other
mammals effective amounts of hydroxycitric acid or a combination of
hydroxycitric acid, chromium and gymnemic acid, which work synergistically to
further to promote healthy body weight and improve these physiological
factors. Type: Application Filed: August 3, 2004 Publication date: January 20, 2005 Applicant: InterHealth Nutraceuticals Incorporated Inventors: Debasis Bagchi, Harry Preuss Compositions incorporating(-)-hydroxycitric acid, chromium, and
gymnemic acid, and related methods for promoting healthy body weight and
improving related health factors Publication number: 20050008722 Abstract: Methods for promoting healthy body weight and improving a
variety of related physiological factors, including serum serotonin levels,
serum leptin levels, fat oxidation, cholesterol levels, and body mass index,
in persons or other mammals, include administering to those persons or other
mammals effective amounts of hydroxycitric acid or a combination of
hydroxycitric acid, chromium and gymnemic acid, which work synergistically to
further to promote healthy body weight and improve these physiological
factors. Type: Application Filed: August 3, 2004 Publication date: January 13, 2005 Applicant: InterHealth Nutraceuticals Incorporated Inventors: Debasis Bagchi, Harry Preuss |
|
|
|
|
GOVERNMENT CONTRACTS |
No records found. |
|
|
|
|
CASES |
Ingram, et. al. v. Interhealth Nutraceuticals Incorporated, et. al. Plaintiff: Keith Hoston, Rapheal Scott, Lavar Bagley, Sr., Daniel
Anckner, Robert Wiliams, Nisha Flowers, Darryl Ingram, Gilbert Rouse, Toni
Boyden and Shirley McDonald Defendant: Iovate Health Sciences Group n/k/a Kerr Investment Holding
Corp, Iovate Health Sciences International, Inc., Vitaquest International
LLC, Garden State Nutritionals, Inc., HVL Incorporated, HVL LLC, Bactolac
Pharmaceutical, Inc., GNC Corporation, General Nutrition Centers, Inc.,
Wal-Mart Stores Inc, Rite Aid Corporation, CVS Pharmacy Inc, CVS Rx Services,
Inc., Walgreens Co., Vitamin World, Inc., Iovate Health Sciences Research,
Inc., Interhealth Nutraceuticals Incorporated, Iovate Health Sciences USA,
Inc. and Iovate Health Sciences, Inc. Respondent: Muscletech Research and Development, Inc. Case Number: 3:2012cv01958 Filed: August 8, 2012 Court: California Southern District Court Office: San Diego Office County: XX US, Outside State Referring Judge: Karen S. Crawford Presiding Judge: Barry Ted Moskowitz Nature of Suit: Personal Injury- Product Liability Cause of Action: 28:1332 Jury Demanded By: Plaintiff Dure et al v. Interhealth Nutraceuticals Incorporated et al Plaintiff: Gerard Dure, James Larson, Christian Gual and Cecil
Singleton Defendant: Iovate Health Sciences, Inc., Iovate Health Sciences Research,
Inc., Iovate Health Sciences Group, Inc. n/k/a Kerr Investment Holding Corp.,
Iovate Health Sciences International, Inc., Muscletech Research and
Development, Inc., Vitaquest International, LLC, Garden State Nutritionals,
Inc., HVL Incorporated, HVL LLC, GNC Corporation, General Nutrition Centers,
Inc., Rite Aid Corporation, Vitamin Shoppe, Inc. and Interhealth
Nutraceuticals Incorporated Case Number: 3:2012cv01959 Filed: August 8, 2012 Court: California Southern District Court Office: San Diego Office County: XX US, Outside State Referring Judge: Karen S. Crawford Presiding Judge: Barry Ted Moskowitz Nature of Suit: Personal Injury- Product Liability Cause of Action: 28:1332 Jury Demanded By: Plaintiff Orangio v. Interhealth Nutraceuticals Incorporated, et. al. Plaintiff: John B. Orangio Defendant: HVL LLC., Bactolac Pharmaceutical Inc., Walgreen Co.,
Iovate Health Sciences Research, Inc., Iovate Health Sciences USA, Inc.,
Iovate Health Sciences, Inc., Iovate Health Sciences Group Inc. n/k/a Kerr
Investment Holding Corp., Iovate Health Sciences International, Inc., Iovate
HC 2005 Formulations Ltd, Muscletech Research and Development, Inc., HVL
Incorporated and Interhealth Nutraceuticals Incorporated Case Number: 3:2012cv01957 Filed: August 8, 2012 Court: California Southern District Court Office: San Diego Office County: XX US, Outside State Referring Judge: Karen S. Crawford Presiding Judge: Barry Ted Moskowitz Nature of Suit: Personal Injury- Product Liability Cause of Action: 28:1332 Jury Demanded By: Plaintiff |
|
|
|
|
TRADEMARKS |
CHROMEMATE CHROMIUM CHEMICAL PREPARATION USED IN THE MANUFACTURE OF NUTRITIONAL
SUPPLEMENTS Owned by: INTERHEALTH NUTRACEUTICALS, INCORPORATED Serial Number: 73786956 VERADIN vitamins sold in bulk form for industrial and/or manufacturing use Owned by: INTERHEALTH NUTRACEUTICALS, INCORPORATED Serial Number: 75406034 STRESSSHIELD3 Carbohydrates used as an ingredient in nutraceuticals, dietary
supplements, food supplements, nutritional supplements, functional… Owned by: INTERHEALTH NUTRACEUTICALS, INCORPORATED Serial Number: 77192159 OPTIHEART Nutritional supplements for heart health; foods made with nutritional
supplements for heart health; beverages made with… Owned by: INTERHEALTH NUTRACEUTICALS, INCORPORATED Serial Number: 78866636 |
|
|
|
|
RENEWAL HISTORY |
Document Type File Date SI-COMPLETE 10/03/2017 SI-COMPLETE 10/16/2014 MERGER 11/26/2013 MERGER 08/08/2006 RESTATED REGISTRATION 12/17/2001 RESTATED REGISTRATION 04/16/1998 RESTATED REGISTRATION 03/31/1997 AMENDMENT 08/14/1996 AMENDMENT 07/30/1996 RESTATED REGISTRATION 05/16/1996 AMENDMENT 10/22/1987 REGISTRATION 10/07/1987 |
|
|
|
|
UCC |
No records found. |
|
|
|
|
OFAC Sanctions List Search |
The company is not listed in the OFAC list. |
|
|
|
SUMMARY |
|
|
|
Interhealth Nutraceuticals Incorporated is a mid-sized, relatively new
organization in the medicinal and botanical company’s industry located in
Benicia, CA. It opened its doors in 1987 and now has an estimated $8.4 million in
yearly revenue and 30 employees. The company operates nationally and internationally, mainly exporting
to Mexico. It is ACTIVE in business with no negative records. |
|
|
|
RISK INFORMATION |
|
|
DEBTS |
Controlled |
|
PAYMENTS |
No Complaints |
|
CASH FLOW |
Normal |
|
STATUS |
Active |
|
|
|
|
INTERVIEW |
|
|
NAME |
Bob |
|
POSITION |
Operator |
|
COMMENTS |
He confirmed the name of the company, the address of the headquarters
and location, the date of creation of the company, the number of employees
and the Contact name. |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
INR 64.07 |
|
|
1 |
INR 91.34 |
|
Euro |
1 |
INR 80.03 |
|
US Dollar |
1 |
INR 64.14 |
Note :
Above are approximate rates obtained from sources believed to be correct
INFORMATION DETAILS
|
Analysis Done by
: |
NIS |
|
|
|
|
Report Prepared
by : |
TPT |
RATING EXPLANATIONS
|
Credit Rating |
Explanation |
Rating Comments |
|
A++ |
Minimum Risk |
Business dealings permissible with minimum
risk of default |
|
A+ |
Low Risk |
Business dealings permissible with low
risk of default |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
B |
Medium Risk |
Business dealings permissible on a regular
monitoring basis |
|
C |
Medium High Risk |
Business dealings permissible preferably
on secured basis |
|
D |
High Risk |
Business dealing not recommended or on
secured terms only |
|
NB |
New Business |
No recommendation can be done due to
business in infancy stage |
|
NT |
No Trace |
No recommendation can be done as the
business is not traceable |
NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors are as follows:
·
Financial
condition covering various ratios
·
Company
background and operations size
·
Promoters
/ Management background
·
Payment
record
·
Litigation
against the subject
·
Industry
scenario / competitor analysis
·
Supplier
/ Customer / Banker review (wherever available)
This report is issued at
your request without any risk and responsibility on the part of MIRA INFORM
PRIVATE LIMITED (MIPL) or its officials.